We are currently supporting our client with the recruitment of a Group Lead / VP - Anti-Infectives in vivo Pharmacology based in the North West of England.
The successful candidate will be part of the anti-infectives in vivo pharmacology team leadership, ensuring delivery of scientific excellence across the entire in vivo anti-infectives platform. They will work closely with the anti-infective senior leadership and colleagues in the in vitro function to deliver the overall anti-infectives in vivo pharmacology strategy including the addition and commercialization of new technologies and experimental techniques to the platform. The individual will also be a key business development interface with clients ensuring delivery of all projects on time and to budget as well as generating technical proposals to win new business
Responsibilities
- Responsible for the management of the anti-infectives in vivo group and activities therein.
- Ensure that projects are prioritized correctly and delivered to agreed quality standards, timelines and budgets.
- Work with Anti-infective SVPs and peers to deliver scientific excellence across the anti-infectives portfolio.
- Ensure benchmarking of the group with regard to current and future developments in the field and industry trends to maximize competitive advantage.
- Undertake medium and short-term planning and supervision of projects, which may require interaction with multiple departments and external clients.
- Assist in the development and management of budgets; allocates resources and monitors project costs; costs are reported on a monthly basis and projects re-budgeted if circumstances change
- Support management with proposal writing and Business Development activities.
- Responsible for the performance management, career development and training of department employees.
- Key interface with clients and collaborators across anti-infective portfolio.
- Serves as a scientific expert contributing at a high level across in vivo pharmacology activities (Innovate and Execute), including PKPD, efficacy models, study design and implementation.
- Ensure robust and high quality scientific practice within the in vivo team, bridging in vitro microbiology.